Qingping Zou
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Pimicotinib versus placebo for tenosynovial giant cell tumour (MANEUVER): an international, randomised, placebo-controlled, phase 3 trial.
Journal: Lancet (London, England)
Published: August 18, 2025
MANEUVER: A Phase III study of pimicotinib to assess efficacy and safety in tenosynovial giant cell tumor patients.
Journal: Future oncology (London, England)
Published: September 17, 2024
Integrated genomic and transcriptomic analysis suggests KRT18 mutation and MTAP are key genetic alterations related to the prognosis between astrocytoma and glioblastoma.
Journal: Annals of translational medicine
Published: May 14, 2021
UHRF1 regulates alternative splicing by interacting with splicing factors and U snRNAs in a H3R2me involved manner.
Journal: Human molecular genetics
Published: February 26, 2021
An epigenetic perspective on tumorigenesis: Loss of cell identity, enhancer switching, and NamiRNA network.
Journal: Seminars in cancer biology
Published: September 06, 2018
An epigenetic perspective on tumorigenesis: Loss of cell identity, enhancer switching, and NamiRNA network.
Journal: Seminars in cancer biology
Published: July 01, 2018
Guide Positioning Sequencing identifies aberrant DNA methylation patterns that alter cell identity and tumor-immune surveillance networks.
Journal: Genome research
Published: June 16, 2018
miRNA-Mediated RNAa by Targeting Enhancers.
Journal: Advances in experimental medicine and biology
Published: June 23, 2017
Steering Against Wind: A New Network of NamiRNAs and Enhancers.
Journal: Genomics, proteomics & bioinformatics
Published: March 02, 2017
MBD3L2 promotes Tet2 enzymatic activity for mediating 5-methylcytosine oxidation.
Journal: Journal of cell science
Published: August 13, 2015
Last Updated: 09/26/2026